Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

Lument Finance Trust, Inc.  ("we,"; "LFT" or the "Company") today announced that it closed LMNT 2025-FL3, a $663.8 million ...

Clinicians Laura Huppert, Kelsey Natsuhara, and Magdelena Ford discuss the evidence, challenges, and real-world ...

The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.

SIR Royalty Income Fund ("the Fund") today declared a cash distribution of $0.10 per unit for the period November 1, 2025 to November 30, 2025 (the "December Distribution"). The Fund also declared a ...

AI and ML applications has intensified thermal demands, but active cooling will protect defence computing platforms. Learn more here: ...

John Johnson, current board member, appointed to chairman of the boardMichael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of developmentCommercial launch progresses as RAMP ...

Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor ...

The changes to the longstanding power imbalance in the doctor-patient relationship in the past generation or so have largely ...

ORLANDO, Fla. — Two Orlando parents are urging state and federal lawmakers to update infant screening after what they describe as life-altering delays in their daughter’s diagnosis and treatment.

Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...

This infographic explores how LFTs work, their key applications and the latest innovations shaping their future.